Calsource

Quick links to important sections

Calsource

Method of action: Mineral, Vitamins

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calsource

This section defines the identity, composition, and general purpose of Calsource, a preparation centered around the active substance Calcium Glubionate, strictly avoiding details related to dosage, usage instructions, or safety warnings.

Property Description
Active Ingredient Calcium Glubionate
Form Oral Solution (Liquid)
Pharmacological Class Calcium Salts, Mineral Supplement
Common Purpose Source of Calcium Ion (Ca^2+)
Origin Synthetic Salt

What Type of Medicine is Calsource?

Calsource is a medicine whose active component is Calcium Glubionate, serving as an oral mineral supplement and an electrolyte replenishing agent designed to provide the body with essential calcium. This preparation is classified under the high-level pharmacological category of Calcium Salts and is recognized for its function in supporting the body's mineral requirements. Calcium Glubionate is a synthetic salt created by combining calcium with gluconic acid and lactobionic acid. This complex organic structure contributes to its high solubility, a factor that is clinically recognized as beneficial for absorption, particularly when administered as a liquid.

How is Calsource Formulated?

The formulation of Calsource is typically an oral solution, which determines its oral route of administration. This single-ingredient preparation consists of the active calcium salt dissolved in an aqueous vehicle. The liquid form provides a highly available source of the mineral, making it a suitable option for individuals requiring consistent mineral intake, such as patients who may struggle with swallowing solid forms.

What is the General Purpose of Taking Calsource?

The general purpose of Calsource is to provide an accessible and absorbable source of calcium ion to support the body's overall mineral balance. Its function is centered on direct mineral delivery and electrolyte replenishment. The benefit of maintaining adequate serum calcium levels is foundational, as this mineral is critical for the structural integrity of bones and teeth, and for enabling key physiological processes like nerve signal transmission and efficient muscle contraction.

What side effects are possible with Calsource?

Possible side effects and safety information

The regulatory safety profile for Calsource, a Calcium Glubionate preparation, focuses primarily on the potential for mineral balance disturbances and their consequences, as documented by official health authorities. Adverse reactions are grouped by system-organ class and frequency, where specified.

Adverse Reactions by System-Organ Class

The most commonly listed adverse effects are related to the Gastrointestinal System and include constipation, nausea, vomiting, abdominal pain, and a decreased appetite (anorexia). Systemic safety concerns fall under Metabolism and Nutrition Disorders and involve the potential for Hypercalcemia (high calcium in the blood) and Hypercalciuria (high calcium in the urine).

Serious Adverse Reactions and Safety Patterns

The most significant risk documented in the long term relates to the Renal and Urinary System. Sustained Hypercalciuria, particularly with prolonged administration, is associated with the potential development of Calcium Nephrolithiasis (kidney stones). Additionally, rare instances of allergic reactions (hypersensitivity) are noted.

Population and Constraint Considerations

The medicine is formally contraindicated in patients with pre-existing Hypercalcemia. Safety notes specify that individuals with a history of recurrent kidney stones require particular caution. Furthermore, the risk of Hypercalcemia may be elevated in patients with hypoparathyroidism who are simultaneously receiving high-dose Vitamin D. Concurrent use with certain Loop Diuretics is noted as an interaction-related safety pattern that increases the risk of Hypercalciuria and stone formation.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Calsource, a Calcium Salt preparation, is officially documented as leading to Hypercalcaemia (excess calcium in the blood). The officially described manifestations of overdose relate directly to this condition and include early signs such as lassitude, anorexia, nausea, vomiting, polyuria, and abdominal pain.

Regulator-Mandated Emergency Actions

The official regulatory profile strictly defines when urgent medical assistance is required. Patients must seek immediate medical attention or contact emergency services if severe symptoms develop or if documented plasma calcium concentrations exceed the established threshold of approximately 2.6 mmol/L. Severe outcomes listed in regulatory documents that warrant immediate help include cardiac arrhythmias, syncope, mental disturbances, and progression to coma.

Official Management and Monitoring

Management procedures, as described in regulatory texts, involve immediately withholding calcium administration. The official approach is symptomatic and supportive, as no specific antidote is known. Supportive measures documented include fluid replacement via rehydration and the use of diuretics to increase calcium excretion. Close monitoring of serum-electrolyte concentrations and continuous ECG monitoring are mandated observation requirements during overdose management.

Therapeutic Uses of Calsource

Quick Facts: Calsource Main Uses

  • Helps manage or prevent conditions associated with low calcium levels.
  • May be used to address calcium deficiency.
  • Supports bone health and maintenance.
  • May help reduce the risk of developing osteoporosis.

Calsource is a medication used to help manage or prevent conditions linked to inadequate calcium intake or low calcium levels in the body. It may be prescribed to address calcium deficiency. Maintaining adequate calcium is important for numerous bodily functions, including nerve, muscle, and bone health.

The medication supports the proper development and maintenance of bone structure. For individuals who may not be able to meet their daily calcium requirements through diet alone, Calsource may be considered to help promote bone mineral density. Sufficient calcium intake can help reduce the risk of developing osteoporosis, a condition characterized by weak and fragile bones.

Calsource may also be used in certain patient populations, such as during periods of increased demand, to help ensure they receive sufficient calcium.

Eligibility and Restrictions for Use

The official regulatory profile for Calsource (Calcium Glubionate Oral Solution) defines patient eligibility based on pre-existing metabolic and renal conditions, as documented by authoritative government sources.

Populations Who Must Not Use Calsource (Contraindications)

Use of Calsource is Contraindicated (strictly prohibited) in patients presenting with conditions that can be worsened by increased calcium levels or which inhibit its proper metabolism. These include:

  • Hypercalcemia (abnormally high serum calcium levels)
  • Renal Calculi (calcium-containing kidney stones)
  • Galactosemia (a specific metabolic disorder)
  • Lactase Deficiency

Established Eligibility and Conditional Use

Use of Calsource is Established across the full age spectrum, from Neonates and Infants through Adults and Older Adults. It is also Documented as Acceptable for use during Pregnancy and Lactation.

However, specific populations require Conditional Use due to increased risk or impaired absorption:

  • Renal Dysfunction: Patients with Renal Dysfunction or Chronic Renal Failure must be monitored closely for an increased risk of developing Hypercalcemia.
  • Urologic History: Patients with a History of Kidney Stones require caution and medical supervision.
  • Achlorhydria: Caution is required in patients with Achlorhydria (low stomach acid), particularly common in older adults, as this condition can impair calcium absorption.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The officially documented interaction profile for Calsource (Calcium Glubionate) is defined by its ability to interfere with the absorption of other oral medicines and by its systemic effects on calcium balance, as detailed in regulatory documents.


Formal Restrictions and Contraindications

Intravenous administration of Ceftriaxone is strictly contraindicated in neonates (28 days of age or younger) due to the documented risk of forming fatal calcium-ceftriaxone precipitates in vital organs.


Exposure Modification and Administration Timing

Calsource can reduce the systemic exposure of several co-administered oral medicines. The calcium ion binds to drugs like Tetracycline Antibiotics and Fluoroquinolone Antibiotics, leading to a decrease in their concentration and effectiveness. To mitigate this chelation-based interference, mandatory timing rules are required: Tetracyclines must be separated by at least 2 hours, and Fluoroquinolones must be separated by 2 hours before or 6 hours after the calcium salt. Bisphosphonates and Eltrombopag also experience decreased systemic exposure.


Pharmacodynamic Effects

Co-administration with Cardiac Glycosides (e.g., Digoxin) carries the documented risk of synergistic arrhythmogenic effects. Combining Calsource with Thiazide Diuretics or Vitamin D Analogs results in an increased risk of hypercalcaemia due to reduced calcium excretion. Furthermore, foods high in oxalic or phytic acid (e.g., spinach, whole grains) may decrease calcium absorption if consumed concurrently.

Mechanism of Action

pH Buffering and Acid Neutralization

The drug initiates a rapid chemical neutralization process in the stomach, where its basic components react directly with hydrochloric acid (HCl), immediately elevating the pH. This mechanism is focused on the upper gastrointestinal system and leads to a significant, temporary reduction in the acidity of the stomach environment. This action limits the chemical activity of the H^+ concentration against the esophageal and stomach mucosal surfaces.


Intestinal Chelation of Dietary Minerals

In the digestive tract, the drug utilizes its unabsorbed calcium ions ( Ca^2+) to engage in chelation, chemically binding to dietary phosphate and oxalate ions. This sequestration mechanism prevents these minerals from being absorbed, thus reducing their systemic load and influencing overall mineral absorption dynamics. This process may contribute to a lower circulating load of these minerals, which influences the systemic mineral load.


Systemic Calcium Ion Supplementation

A portion of the drug's Ca^2+ is absorbed, directly supplementing the circulating pool of ionized calcium. This essential mineral is integral to numerous pathways, including nerve signaling and muscle contraction, and its supplementation provides circulating Ca^2+ for utilization in these Ca^2+-dependent biological functions. This increase in circulating ionized calcium supports Ca^2+-dependent physiological activities, including nerve impulse transmission, muscle contraction, and skeletal tissue maintenance.

Dosage and Administration Information

How Calsource is Used: Official Administration Guidelines

Calsource is an oral mineral supplement containing Calcium Glubionate, and its use is strictly confined to the oral route of administration as an official liquid solution. Administration guidelines define precise dosing and consumption patterns, independent of clinical efficacy or safety concerns.

Official Dosing and Frequency

Patient Population Standard Dosing Regimen (Volume) Frequency
Adults and Adolescents (≥ 4 yrs) 15 mL per dose Three times a day (TID)
Children (< 4 yrs) 10 mL per dose Three times a day (TID)
Infants (< 12 months) 5 mL per dose Five times a day

The standard 15 mL dose provides 345 mg of elemental calcium, based on the common solution strength of 1.8 g Calcium Glubionate per 5 mL.

Administration Conditions

To ensure proper use, specific contextual and procedural conditions must be observed:

  • Timing: The solution is instructed to be administered before meals for most established adult and pediatric regimens.
  • Measurement: Accurate volumetric measurement, typically in milliliters (mL), is required for all doses to ensure the correct amount of the oral solution is taken.
  • Pediatric Preparation: For infants and children, the liquid dose may be mixed with juice or formula to assist with administration.
  • Renal Consideration: Administration in patients with reduced kidney function is guided by the procedural constraint of periodic monitoring of serum calcium levels, as specified in official prescribing information.

This structured approach defines the standard method for taking the medicine, focusing exclusively on the official dose, volume, frequency, and preparation steps.

Recent Clinical Evidence

Evidence for Managing Chronic Low Calcium Levels

Research has examined the active ingredient, Calcium Glubionate, in the context of providing a source of calcium. This research is characterized by long-standing consensus in the scientific literature rather than large clinical trials. Evidence includes short-term clinical studies and observational analyses that research examined how different forms of oral calcium were processed. Outcomes monitored included the measurements of serum calcium and ionized calcium concentrations in the blood. Findings describe patterns observed in the studies related to mineral delivery. The evidence base for this specific salt data are still emerging, and findings often use extrapolation from the general class of bioavailable calcium salts.


Research on Bone Health Support and Osteoporosis Risk

The use of oral calcium salts was evaluated in numerous large-scale clinical investigations for conditions like osteoporosis and bone health maintenance. The main evidence is derived from Randomized Controlled Trials (RCTs), often conducted with calcium and Vitamin D combined, as well as Systematic Reviews and Meta-analyses. These studies research examined changes in Bone Mineral Density (BMD) and tracked the incidence of bone fractures over time. Research data show patterns related to BMD. However, findings were mixed when it came to examining nonvertebral fracture incidence. The changes measured during the study period for calcium was observed in some studies to be dependent on the concomitant use of Vitamin D.


Remaining Research Context and Gaps

For research examining long-term outcomes, studies focusing on bone health typically involve intermediate to long-term follow-up durations (often two or more years). However, long-term effects are not fully established for the specific Calsource formulation. Research has largely focused on specific groups who was studied for needs related to calcium, predominantly postmenopausal women and older men. Data for certain groups remain insufficient. Overall, subgroup findings are uncertain or evidence is limited for specific outcomes, and data for this specific salt often require extrapolation from other calcium salts.

Frequently Asked Questions (FAQ)

Common questions about Calsource (FAQ)


Q: Is Calsource the same as other medicines for the same condition?

A: Calsource contains a specific substance known as Calcium Glubionate. While this substance belongs to the broader pharmacological class of Calcium Salts used for mineral supplementation, it is one unique formulation within that group, as defined by official product information.


Q: Why do some people say Calsource works slowly?

A: The systemic effect of Calsource involves delivering the calcium ion to the body's circulating pool. Official monitoring guidelines indicate that the full effect on blood calcium levels is assessed over a period of several hours following administration.


Q: How long does Calsource take to start working?

A: Systemic calcium levels are generally monitored on a schedule of every four to six hours to assess the effect of the dose on the patient's mineral balance. This monitoring schedule is based on official protocols.


Q: What happens if I miss taking Calsource one day?

A: Regulatory documents provide instructions for a missed dose. If a dose is missed, it should be taken when remembered. If it is close to the time for your next scheduled dose, the regulatory guidance indicates that the missed dose should be skipped. Official instructions warn not to double the dose to compensate.


Q: Does Calsource cause weight gain or loss?

A: The official adverse reaction lists include decreased appetite ( anorexia) as a possible side effect of Calsource. However, weight gain or weight loss as an explicit side effect is not generally listed in regulatory documents.


Q: Is it normal to feel tired after starting Calsource?

A: Official warnings note that feeling tired ( fatigue or weakness) can be a potential symptom associated with Hypercalcemia. Hypercalcemia means abnormally high calcium levels in the blood, which is a serious condition described in the product safety information.


Q: Can I take Calsource if I also take a vitamin supplement?

A: Since calcium salts may affect the absorption of other oral medicines and supplements in the digestive tract, official guidance advises caution. Official guidance notes that patients should inform a healthcare provider about all supplements, including vitamins, before starting or continuing Calsource.


Q: Does Calsource interact with herbal supplements like St. John's Wort?

A: Official regulatory guidance requires that patients inform a healthcare provider about all products they are using, including all herbal supplements. Official guidance notes that patients should inform a healthcare provider about all products, including herbal supplements, before taking Calsource to review the interaction profile.


Q: Can Calsource affect my mood or mental health?

A: Official warnings indicate that Hypercalcemia (high blood calcium) can lead to symptoms, including changes in mental status such as confusion. This potential effect is documented in the product's safety information.


Q: Why is Calsource sometimes given with other medications?

A: Official dosing guidelines and treatment regimens show that Calsource may be prescribed as part of a combined treatment program. This is often done alongside other agents, such as Vitamin D, to manage conditions like hypocalcemia or support bone health.


Q: What is the earliest age a person can be prescribed Calsource?

A: The official dosing guidelines include a defined, recommended regimen for Neonates (newborns) for certain conditions requiring calcium supplementation. This age group is specifically defined in the regulatory documents for administration.


Q: Are there different strengths of Calsource available?

A: According to the official prescribing information, Calsource is typically available in a single concentration for the oral solution. The concentration is formally defined as 1.8 g Calcium Glubionate per 5 mL.


Q: Can Calsource be split or crushed to make it easier to swallow?

A: Calsource is formulated and marketed as an oral solution (liquid). Therefore, the procedural instructions regarding the splitting or crushing of solid tablets do not apply to this product.


Q: Does Calsource affect fertility in men or women?

A: Official regulatory documents often indicate that controlled human data on reproductive effects or fetal harm related to the drug's use are not available. This reflects the current state of published clinical data.


Q: Can Calsource make me dizzy or affect my ability to drive?

A: Official product information notes dizziness as a potential side effect. Official documentation includes caution statements regarding driving or operating machinery for patients who experience dizziness or other nervous system effects.


Q: Can Calsource be used for pain management?

A: The official Indications and Usage section for Calsource defines its purpose as providing a calcium source for conditions related to low calcium levels ( hypocalcemia). The medicine is not officially indicated for pain management.


Q: Are there any foods or drinks I need to avoid while on Calsource?

A: The official interaction profile states that certain foods can affect how the calcium is absorbed. Specifically, foods high in oxalic acid (like spinach) or phytic acid (like whole grains) may interfere with calcium absorption if consumed with the medicine.


Q: What is the shelf life or expiry of Calsource tablets?

A: The official storage and disposal instructions require the product to be discarded after the expiration date printed on the label. This is a standard safety requirement for all medications, including the Calsource liquid solution.


Q: Is it true that Calsource is affected by sunlight?

A: Official storage instructions mandate keeping the container tightly closed and protecting the liquid from moisture and excess heat. Protecting the medicine from extreme conditions helps ensure its stability.


Q: Is Calsource generally considered a long-term treatment?

A: Official warnings indicate that the safety of long-term use for calcium salts is not fully established. Prolonged use may be associated with increased risks, such as the potential for kidney stone formation over time.


Q: Is Calsource known to cause allergic reactions?

A: Official adverse reaction reports note allergic reactions ( hypersensitivity) as a rare potential risk associated with Calsource. The safety information lists signs of an allergic reaction, such as hives or swelling, as conditions that require medical attention.


Q: Does Calsource change how other medications are absorbed?

A: Yes. The official Interactions section explains that the medicine can reduce the systemic exposure of several co-administered oral medicines. This occurs because the calcium ion can chemically bind (chelate) to other drugs in the digestive tract.


Q: What is the difference between Calsource and a supplement?

A: Calsource is classified by government regulators as both a medicine (prescription product) and an oral mineral supplement. It is a calcium salt intended to replenish calcium in the body to support mineral balance.


Q: Are there any large clinical trials for Calsource I can read about?

A: Research examining calcium salts includes large Randomized Controlled Trials ( RCTs) and Systematic Reviews. Evidence for the specific Calsource salt often relies on extrapolation from the general class of bioavailable calcium salts.


Q: Is Calsource a type of steroid or hormone?

A: No. Calsource is officially classified as a Calcium Salt and a Mineral Supplement. It is not categorized as a steroid or as a hormone by regulatory agencies.

How should Calsource be stored and disposed of?

Calsource (Calcium Glubionate Oral Solution) must be stored strictly according to official regulatory requirements to maintain its stability. The medication should be kept at controlled room temperature, generally between 15 C to 30 C.

Storage Requirements

  • Temperature: Store at room temperature; do not freeze and keep away from excess heat.
  • Protection: Keep the container tightly closed and protect the liquid from moisture.
  • Child Safety: It is mandatory to store Calsource out of the reach of children and out of their sight.

Disposal Instructions

  • Unused Product: Discard any outdated or no longer needed medicine after the expiration date.
  • Procedure: Consult a pharmacist or healthcare provider for official advice on how to properly dispose of the unused solution. Regulatory guidance recommends avoiding disposal into sewer systems or the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calsource found in:

A-Z Index: